Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

PSA’s projects make a bigger impact than ever before

The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Age of anxiety

Anxiety is the most common mental health condition in Australia, and research shows the pandemic has only exacerbated the issue. Are we doing enough to support those who experience it?

Q&A: Shadow Federal Health Minister Catherine King

As a supporter of pharmacists, Catherine King MP is a firm believer in having a ‘broader’ role for pharmacists in Australia’s health system. During her...

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Harnessing different abilities

Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...